Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT05680207 Completed - Clinical trials for Diabetes Mellitus, Type 2

Empowerment Training on Type 2 Diabetes Patients on Empowerment Levels and Clinical Findings

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

In this study, the effect of nurse-led empowerment training given to patients with Type 2 Diabetes on clinical findings and empowerment behaviors will be investigated.

NCT ID: NCT05676619 Completed - Clinical trials for Diabetes Complications

3D Foot Scanner Reliability for Footwear Fit and Design

Start date: February 16, 2023
Phase: N/A
Study type: Interventional

The investigators will carry out a proof-of-concept study in 20 adult healthy male and female volunteers in order to: assess a 3D foot scanner's reliability. Specifically, the investigators will assess its variability during repeated foot scans of the same subject's foot. Three repeated foot scans will be carried out by two different examiners to measure intrarater and interrater reliability (Intraclass Correlation Coefficient

NCT ID: NCT05668442 Completed - Clinical trials for Diabetes Mellitus, Type 2

Feasibility of an Online Exercise Community Among Individuals With Type 2 Diabetes

Start date: November 21, 2020
Phase:
Study type: Observational

The aim of this study is to evaluate the feasibility, fidelity and acceptability of an 8-week high intensity online physical exercise combined with online group meetings and supported with an activity tracker in individuals with type 2 diabetes. The design of the intervention will be developed using a co-creation approach. The intervention consist of eight weeks of 30 minutes online physical exercise followed by 30 minutes of online group meeting in Microsoft Teams once a week. Outcomes includes pre-defined research progression criteria and secondary outcomes of physical and mental health and participant feedback.

NCT ID: NCT05667051 Completed - Diabetes Mellitus Clinical Trials

Endocan Biomarker Level in Gingival Crevicular Fluid in Periodontitis Patients With Type 2 Diabetes Mellitus

Start date: April 5, 2022
Phase:
Study type: Observational

Aim of the current study was to evaluate Endocan biomarker level in gingival crevicular fluid of patients with stage 1 or 2 (mild to moderate) periodontitis with controlled type 2 diabetes mellitus (DM) and compare it to that in DM free periodontitis patients.

NCT ID: NCT05662930 Completed - Hypertension Clinical Trials

Evaluation Of Stress Response In Diabetic Hypertensive Patients

Start date: June 1, 2016
Phase:
Study type: Observational

In this research, we aimed to examine salivary cortisol changes in the cognitive stress response of patients with Hypertension + Diabetes Mellitus (HT+DM) and Hypertension (HT) and to determine the differences between them. The research was conducted by solving an arithmetic task as a stress test in 62 patients with HT+DM and HT that are being treated in the outpatient clinic of Medical Pharmacology and Clinical Pharmacology Department at Istanbul University, Istanbul Medical Faculty Hospital.

NCT ID: NCT05659537 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Start date: December 29, 2022
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to evaluate safety of dulaglutide in participants with type 2 diabetes mellitus in India.

NCT ID: NCT05658744 Completed - Clinical trials for Diabetes Mellitus, Type 2

Video Training to Reduce Insulin Administration Errors

Start date: December 25, 2019
Phase: N/A
Study type: Interventional

Efficiency of training with video to reduce injection errors in patients using insulin

NCT ID: NCT05654727 Completed - Clinical trials for Cognitive Impairment

Cognitive Functions and BDNF in T2DM and Prediabetes Patients

Start date: July 1, 2021
Phase:
Study type: Observational

Clinical and epidemiological studies suggest links between cognitive impairments and Type 2 diabetes (T2DM). The underlying mechanisms and causality in diabetes-related cognitive impairment are largely unknown. The aim of this study is to investigate cognitive impairment and the role of BDNF in prediabetes and diabetes patients.

NCT ID: NCT05654285 Completed - Obesity Clinical Trials

Enteroendocrine Hormonal Response After the Ingestion of Cola Beverages With Sucrose and Non-nutritive Sweeteners

Start date: February 8, 2016
Phase: N/A
Study type: Interventional

Introduction: The consumption of non-nutritive sweeteners (NNS) has been increasing in recent years, as an alternative to replace sugars and reduce the additional intake of carbohydrates, with the idea of reducing the risk of developing obesity, metabolic syndrome, and diabetes. However, recent evidence shows that their chronic intake induces endocrine alterations that may have an important contribution to the increase in body weight. Few studies have explored the acute effects of NNS beverage consumption on endocrine response, and to date, the evidence has been inconsistent regarding post-drinking effects and potential health risks. Objective: To evaluate the effect of 3 different types of cola beverages, compared with carbonated water, on glucose, insulin, glucagon, and appetite-regulating hormones during the first 120 minutes after ingestion. Methods: A triple-blind, randomized crossover controlled trial was carried out in which 20 healthy adult individuals (10 men and 10 women) were included. With a washout period of one week (7 days) and fasting for 8 hours, each participant consumed orally 355 mL of carbonated water (CAR), and the 3 different cola beverages sweetened with sucrose (SUC), aspartame/acesulfame K (ASP), and sucrose/stevia (STE), in its commercial presentation. The serum levels of glucose, insulin, glucagon, GLP-1, GIP, PYY, leptin, pancreatic polypeptide, and ghrelin were determined during the administration of each one of the drinks before the intake of the drink and later at 30, 60, 90, and 120 minutes. Statistical analysis: A descriptive analysis of the variables was performed. The global response of glucose, insulin and appetite-regulating hormones was estimated and the Area Under the Curve (AUC) was obtained using a trapezoidal model and analyzed for each outcome by one-factor ANOVA. An ANOVA for repeated measures was performed considering treatment and time as factors, and comparisons were made with the carbonated water as a control using the Bonferroni test. P values less than 0.05 were considered statistically significant. Ethical considerations: Our institution's Research, Bioethics, and Biosafety committees authorized the project. All the participants were informed about the objective, the procedures, and the possible adverse effects considered within the study, and they signed the informed consent before the start of the interventions.

NCT ID: NCT05647824 Completed - Diabetes Mellitus Clinical Trials

User Performance of the TV4 BGMS

Start date: February 5, 2020
Phase:
Study type: Observational

Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also called study staff).